Table 2 Patients’ characteristics in Leucine enriched and standard BCAA dietary supplements
Dietary supplement | Leucine enriched BCAA | Standard BCAA | |
|---|---|---|---|
n | 15 | 14 | p |
Age, median (IQR) years | 82 (77–92) | 80.5 (77.8–86.3) | ns |
Female (Sex), n (%) | 9 (60%) | 9 (64.3%) | ns |
GCS, median (IQR) | 9 (7–14) | 9.5 (6.25–13) | ns |
BMI, median (IQR) | 21.8 (17.6–23.5) | 19.8 (16.4–22.9) | ns |
On admission | |||
Alb, median (IQR) | 3.5 (3–4.1) | 3.3 (3–3.7) | ns |
TTR, median (IQR) | 12.7 (12–17.2) | 10.7 (8.25–13.0) | ns |
CRP, median (IQR) | 1.02 (0.115–3.705) | 0.673 (0.142–2.961) | ns |
Cre, median (IQR) | 0.78 (0.71–1.04) | 0.695 (0.51–0.91) | ns |
On the 5th day | |||
Alb, median (IQR) | 2.6 (2.4–3.0) | 2.6 (2.3–2.9) | ns |
TTR, median (IQR) | 11.8 (7.3–12.6) | 9.65 (7.83–11.9) | ns |
CRP, median (IQR) | 5.243 (3.038–10.404) | 4.077 (0.700–6.369) | ns |
Cre, median (IQR) | 0.74 (0.65–2.06) | 0.63 (0.50–0.88) | < 0.05 |
On the 7th day | |||
Alb, median (IQR) | 2.6 (2.4–2.9) | 2.5 (2.2–2.8) | ns |
TTR, median (IQR) | 15.7 (10.2–20.2) | 10.7 (8.3–12) | < 0.05 |
CRP, median (IQR) | 4.774 (1.183–6.563) | 2.459 (0.921–5.656) | ns |
Cre, median (IQR) | 0.79 (0.63–2.03) | 0.62 (0.47–0.86) | ns |
Enteral nutrient (baseline) | |||
Impact | 1 | 3 | |
Peptamen AF | 4 | 7 | |
Mein | 7 | 3 | |
Renalen MP | 3 | 1 | |